| Whole-genome sequencing reveals host factors underlying critical COVID-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature 607 (7917), 97-103, 2022 | 222 | 2022 |
| A first update on mapping the human genetic architecture of COVID-19 Writing group lead Andrews Shea J. 6 Kanai Masahiro 3 Cordioli Mattia 7, ... Nature 608 (7921), E1-E10, 2022 | 92 | 2022 |
| Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19 G Povysil, G Butler-Laporte, N Shang, C Wang, A Khan, M Alaamery, ... The Journal of clinical investigation 131 (14), 2021 | 65 | 2021 |
| Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality J Alghamdi, M Alaamery, T Barhoumi, M Rashid, H Alajmi, N Aljasser, ... Genomics 113 (4), 1733-1741, 2021 | 52 | 2021 |
| Risk of neuropsychiatric adverse effects of lipid-lowering drugs: a mendelian randomization study J Alghamdi, S Matou-Nasri, F Alghamdi, S Alghamdi, M Alfadhel, ... International Journal of Neuropsychopharmacology 21 (12), 1067-1075, 2018 | 34 | 2018 |
| Nationwide seroprevalence of SARS-CoV-2 in Saudi arabia NK Alharbi, S Alghnam, A Algaissi, H Albalawi, MW Alenazi, ... Journal of infection and public health 14 (7), 832-838, 2021 | 33 | 2021 |
| Fundamentals of complex trait genetics and association studies J Alghamdi, S Padmanabhan Handbook of pharmacogenomics and stratified medicine 1, 235-257, 2014 | 31 | 2014 |
| SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues M D’Antonio, JP Nguyen, TD Arthur, H Matsui, BM Neale, M Daly, ... Cell reports 37 (7), 2021 | 27 | 2021 |
| Association between IL-37 gene polymorphisms and risk of HBV-related liver disease in a Saudi Arabian population MR Al-Anazi, S Matou-Nasri, AA Al-Qahtani, J Alghamdi, AA Abdo, ... Scientific Reports 9 (1), 7123, 2019 | 21 | 2019 |
| Eye color prediction using single nucleotide polymorphisms in Saudi population J Alghamdi, M Amoudi, AC Kassab, M Al Mufarrej, S Al Ghamdi Saudi journal of biological sciences 26 (7), 1607-1612, 2019 | 19 | 2019 |
| The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort M Al Ammari, M AlBalwi, K Sultana, IB Alabdulkareem, B Almuzzaini, ... Scientific Reports 10 (1), 11613, 2020 | 16 | 2020 |
| Clinical Pharmacology Applications in Clinical Drug Development and Clinical Care: A Focus on Saudi Arabia A Alsultan, WA Alghamdi, J Alghamdi, AF Alharbi, A Aljutayli, A Albassam, ... Saudi Pharmaceutical Journal, 2020 | 13 | 2020 |
| Failure to replicate the association of rare loss-of-function variants in type I IFN immunity genes with severe COVID-19 G Povysil, G Butler-Laporte, N Shang, C Weng, A Khan, M Alaamery, ... medRxiv, 2020 | 11 | 2020 |
| Angiotensin II exaggerates SARS-CoV-2 specific T-cell response in convalescent individuals following COVID-19 M Almutlaq, FA Mansour, J Alghamdi, Y Alhendi, AA Alamro, AA Alghamdi, ... International Journal of Molecular Sciences 23 (15), 8669, 2022 | 9 | 2022 |
| Identification of novel mutations in colorectal cancer patients using AmpliSeq comprehensive cancer panel B Almuzzaini, J Alghamdi, A Alomani, S AlGhamdi, AA Alsharm, ... Journal of Personalized Medicine 11 (6), 535, 2021 | 7 | 2021 |
| Impact of the 2017 ACC/AHA guideline on the prevalence of elevated blood pressure and hypertension: a cross-sectional analysis of 10 799 individuals M Alyabsi, R Gaid, A Alqunaibet, A Alaskar, A Mahmud, J Alghamdi BMJ open 10 (12), e041973, 2020 | 7 | 2020 |
| Interleukin-22 Polymorphisms in Plasmodium falciparum-Infected Malaria Patients NH Aljarba, MR Al-Anazi, MI Shafeai, FH Rudiny, SM Bin Dajem, ... Mediators of Inflammation 2020, 2020 | 7 | 2020 |
| Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study K Al Sulaiman, O Aljuhani, GB Korayem, A Hafiz, M Alalawi, HA Badreldin, ... Thrombosis Journal 20 (1), 74, 2022 | 6 | 2022 |
| The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study K Al Sulaiman, O Aljuhani, GB Korayem, AF Altebainawi, S Al Harbi, ... Frontiers in Public Health 10, 877944, 2022 | 6 | 2022 |
| Blood pressure–lowering activity of statins: a systematic literature review and meta-analysis of placebo-randomized controlled trials J Alghamdi, A Alqadi, A Alharf, B Almuzzaini, A Mahmud, T Barhoumi, ... European Journal of Clinical Pharmacology 76, 1745-1754, 2020 | 5 | 2020 |
